Literature DB >> 15337287

3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.

C X Xue1, S Y Cui, M C Liu, Z D Hu, B T Fan.   

Abstract

The 3D QSAR analyses of antimalarial alkoxylated and hydroxylated chalcones were first conducted by Comparative molecular field analysis (CoMFA) and Comparative similarity indices analysis (CoMSIA) to determine the factors required for the activity of these compounds. Satisfactory results were obtained after performing a leave-one-out (LOO) cross-validation study with cross-validation q(2) and conventional r(2) values of 0.740 and 0.972 by the CoMFA model, 0.714 and 0.976 by the CoMSIA model, respectively. The results provided the tools for predicting the affinity of related compounds, and for guiding the design and synthesis of novel and more potent antimalarial agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337287     DOI: 10.1016/j.ejmech.2004.05.009

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  21 in total

1.  Anti-malarial, cytotoxicity and molecular docking studies of quinolinyl chalcones as potential anti-malarial agent.

Authors:  Asima Hameed; Sara Masood; Aamir Hameed; Ejaz Ahmed; Ahsan Sharif; Muhammad Imran Abdullah
Journal:  J Comput Aided Mol Des       Date:  2019-07-03       Impact factor: 3.686

2.  3D-QSAR studies on caspase-mediated apoptosis activity of phenolic analogues.

Authors:  Yuanqiang Wang; Heng Zhang; Yong Lin; Qi Zhao; Hui Liu; Zhan Zhang; Qingyou Xia; Bo Zhu; Zhihua Lin
Journal:  J Mol Model       Date:  2010-03-21       Impact factor: 1.810

3.  Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening.

Authors:  Liying Zhang; Denis Fourches; Alexander Sedykh; Hao Zhu; Alexander Golbraikh; Sean Ekins; Julie Clark; Michele C Connelly; Martina Sigal; Dena Hodges; Armand Guiguemde; R Kiplin Guy; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2013-01-23       Impact factor: 4.956

4.  Understanding electrostatic and steric requirements related to hypertensive action of AT(1) antagonists using molecular modeling techniques.

Authors:  Danielle da C Silva; Vinicius G Maltarollo; Emmanuela Ferreira de Lima; Karen Cacilda Weber; Kathia M Honorio
Journal:  J Mol Model       Date:  2014-06-17       Impact factor: 1.810

5.  (E)-3-[4-(Dodec-yloxy)phen-yl]-1-(2-hydroxy-phen-yl)prop-2-en-1-one.

Authors:  Ibrahim Abdul Razak; Hoong-Kun Fun; Zainab Ngaini; Siti Muhaini Haris Fadzillah; Hasnain Hussain
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-04-25

6.  (E)-3-[4-(Dec-yloxy)phen-yl]-1-(4-hydroxy-phen-yl)prop-2-en-1-one.

Authors:  Ibrahim Abdul Razak; Hoong-Kun Fun; Zainab Ngaini; Norashikin Irdawaty Abd Rahman; Hasnain Hussain
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-04-22

7.  (E)-3-[4-(Hex-yloxy)phen-yl]-1-(2-hydroxy-phen-yl)prop-2-en-1-one.

Authors:  Zainab Ngaini; Siti Muhaini Haris Fadzillah; Hasnain Hussain; Ibrahim Abdul Razak; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-05-14

8.  (E)-3-[4-(Hex-yloxy)phen-yl]-1-(4-hydroxy-phen-yl)prop-2-en-1-one.

Authors:  Ibrahim Abdul Razak; Hoong-Kun Fun; Zainab Ngaini; Norashikin Irdawaty Abd Rahman; Hasnain Hussain
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-05-29

9.  (E)-3-(4-Decyl-oxyphen-yl)-1-(2-hydroxy-phen-yl)prop-2-en-1-one.

Authors:  Zainab Ngaini; Norashikin Irdawaty Abd Rahman; Hasnain Hussain; Ibrahim Abdul Razak; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-28

10.  (E)-1-(4-Decyl-oxyphen-yl)-3-(2-hy-droxy-phen-yl)prop-2-en-1-one.

Authors:  Zainab Ngaini; Siti Muhaini Haris Fadzillah; Hasnain Hussain; Ibrahim Abdul Razak; Safra Izuani Jama Asik
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.